BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28398414)

  • 1. Oral contraceptives for acne treatment: US Dermatologists' knowledge, comfort, and prescribing practices.
    Fitzpatrick L; Mauer E; Chen CL
    Cutis; 2017 Mar; 99(3):195-201. PubMed ID: 28398414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential prescribing of type of combined oral contraceptive pill by general practitioners to teenagers with acne.
    Rowlands S; Devalia H; Lawrenson R
    Eur J Contracept Reprod Health Care; 2001 Mar; 6(1):9-13. PubMed ID: 11334479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isotretinoin and oral contraceptive use in female acne patients varies by physician specialty: analysis of data from the National Ambulatory Medical Care Survey.
    Landis ET; Levender MM; Davis SA; Feneran AN; Gerancher KR; Feldman SR
    J Dermatolog Treat; 2012 Aug; 23(4):272-7. PubMed ID: 22380867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey of Australian dermatologists' perceptions and experiences with isotretinoin-induced depression and suicide.
    Rea S; Tucker S; Frittelli V; Gunnarsson R
    Australas J Dermatol; 2017 Nov; 58(4):323-324. PubMed ID: 28726271
    [No Abstract]   [Full Text] [Related]  

  • 5. Physicians underutilize topical retinoids in the management of acne vulgaris: analysis of U.S. National Practice Data.
    Balkrishnan R; Fleischer AB; Paruthi S; Feldman SR
    J Dermatolog Treat; 2003 Sep; 14(3):172-6. PubMed ID: 14522620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Oral Contraceptives for Management of Acne Vulgaris: Practical Considerations in Real World Practice.
    Harper JC
    Dermatol Clin; 2016 Apr; 34(2):159-65. PubMed ID: 27015775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of topical retinoids by dermatologists and non-dermatologists in the management of acne vulgaris.
    Pena S; Hill D; Feldman SR
    J Am Acad Dermatol; 2016 Jun; 74(6):1252-4. PubMed ID: 27185427
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterizing the relationship between free drug samples and prescription patterns for acne vulgaris and rosacea.
    Hurley MP; Stafford RS; Lane AT
    JAMA Dermatol; 2014 May; 150(5):487-93. PubMed ID: 24740450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris.
    Koo EB; Petersen TD; Kimball AB
    J Am Acad Dermatol; 2014 Sep; 71(3):450-9. PubMed ID: 24880665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of prescribing isotretinoin: focus on women of childbearing potential.
    Doering PL; Araujo OE; Frohnapple DJ; LaMarre AS; Flowers FP
    Ann Pharmacother; 1992 Feb; 26(2):155-61. PubMed ID: 1554922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
    van Vloten WA; van Haselen CW; van Zuuren EJ; Gerlinger C; Heithecker R
    Cutis; 2002 Apr; 69(4 Suppl):2-15. PubMed ID: 12096825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers and Facilitators Affecting Long-Term Antibiotic Prescriptions for Acne Treatment.
    Festok RA; Ahuja AS; Chen JY; Chu L; Barron J; Case K; Thompson E; Chen SC; Weiss J; Swerlick RA; Escoffery C; Yeung H
    JAMA Dermatol; 2024 May; 160(5):535-543. PubMed ID: 38568616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatologists' attitudes, prescription, and counseling patterns for isotretinoin: a questionnaire-based study.
    Nagler AR; Orlow SJ
    J Drugs Dermatol; 2015 Feb; 14(2):184-9. PubMed ID: 25689814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
    Dinger J; Assmann A; Möhner S; Minh TD
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of in-office samples on dermatologists' prescribing habits: a retrospective review.
    DeNigris J; Malachowski SJ; Miladinović B; Nelson CG; Patel NS
    Cutis; 2020 Jan; 105(1):E24-E28. PubMed ID: 32074163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acne with oral contraceptives: criteria for pill selection.
    Koulianos GT
    Cutis; 2000 Oct; 66(4):281-6. PubMed ID: 11109151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Little knowledge and limited practice: emergency contraceptive pills, the public, and the obstetrician-gynecologist.
    Delbanco SF; Mauldon J; Smith MD
    Obstet Gynecol; 1997 Jun; 89(6):1006-11. PubMed ID: 9170482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in prescribing behavior of systemic agents used in the treatment of acne among dermatologists and nondermatologists: A retrospective analysis, 2004-2013.
    Barbieri JS; James WD; Margolis DJ
    J Am Acad Dermatol; 2017 Sep; 77(3):456-463.e4. PubMed ID: 28676330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acne therapy. Medication use and sources of care in office-based practice.
    Stern RS
    Arch Dermatol; 1996 Jul; 132(7):776-80. PubMed ID: 8678569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine prescribing and monitoring practices among Irish dermatologists and rheumatologists.
    Gilhooley E; Feighery C; Collins SM
    Br J Dermatol; 2017 Mar; 176(3):831-832. PubMed ID: 27868183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.